Cilcare Updates License Agreement with Sanofi, Brings Pharma Giant on as Equity Holder
The biotech secures improved royalty terms on its two lead hearing loss programs, CIL001 and CIL003, while Sanofi takes a minority stake in the company.
The biotech secures improved royalty terms on its two lead hearing loss programs, CIL001 and CIL003, while Sanofi takes a minority stake in the company.
The veteran disability rights attorney and telecommunications advocate will join the board effective July 1, 2026, bringing decades of federal policy experience.
If approved, Regeneron's Otarmeni will be the first gene therapy for OTOF-related hearing loss in the European Union.
The integration embeds on-demand language services into virtual care workflows to support patients who are Deaf, hard of hearing, or have limited English proficiency.
Read MoreThe new ready-to-wear ITE device features the company’s Integrated Xperience platform in a small, rechargeable form factor.
Read MoreThe “Soundcheck your career” initiative aims to introduce the next generation of professionals to the hearing care industry.
Read MoreThe acquisition expands the telehealth provider’s in-person tinnitus and audiology services to the San Francisco Bay Area.
Read MoreThe changes are designed to address workforce needs and create clearer routes to accreditation for both overseas-qualified and Australian audiologists.
Read MoreThe update includes new connectivity features, enhanced durability, and more efficient clinical tools for HCPs serving military personnel and veterans.
Read MoreThe new additions include an in-the-ear rechargeable, a flexible miniBTE R, and a zinc-air miniRITE T model designed for government services audiologists and their patients.
Read MoreThe addition of CIC Rechargeable Custom IX, Silk IX, and Active Pro IX completes the company’s Integrated Xperience platform for the VA, DoD, and IHS.
Read MoreAt AAA 2026, a panel of industry executives explored the impact of artificial intelligence, a looming talent shortage, and the critical need to reframe hearing loss as a core health issue.
Read MoreThe AI-driven software analyzes otoscopy videos to detect eardrum bulging, establishing a new regulatory category for ENT diagnostic aids.
Read MoreThe company plans a clinical trial for its CIL001 drug candidate at Massachusetts General Hospital and will triple preclinical capacity through its partnership with CBSET.
Read MoreThe award highlights the discreet hearing aid’s design, innovation, and user-centered features.
Read MoreThe resolution acknowledges the organization’s contributions to the hearing aid specialist profession.
Read MoreThe in-the-ear hearing aid has now received five industry awards for its design and performance since its August 2025 launch.
Read MoreThe company’s OtoKiosk digital audiometer and Amplifon App were recognized by the UX Design Awards and iF Design Awards for user experience and innovation.
Read More